515 related articles for article (PubMed ID: 17452970)
1. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
3. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
4. Natural history of graves' orbitopathy after treatment.
Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
[TBL] [Abstract][Full Text] [Related]
5. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
6. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
Juri J; Stiglmayer N; Kuzman T
Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
[TBL] [Abstract][Full Text] [Related]
7. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
10. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and side effects of 'swinging eyelid' orbital decompression in Graves' orbitopathy: a proposal for standardized evaluation of diplopia.
Paridaens D; Lie A; Grootendorst RJ; van den Bosch WA
Eye (Lond); 2006 Feb; 20(2):154-62. PubMed ID: 15746952
[TBL] [Abstract][Full Text] [Related]
13. [Graves' orbitopathy].
Eckstein A; Esser J
Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
[TBL] [Abstract][Full Text] [Related]
14. [Is incidence of diplopia after Fat Removal Orbital Decompression a predictive factor of choice of surgical technique for Graves' ophthalmopathy?].
Adenis JP; Camezind P; Robert PY
Bull Acad Natl Med; 2003; 187(9):1649-58; discussion 1659-60. PubMed ID: 15369235
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for Graves' orbitopathy.
Marcocci C; Altea MA; Leo M
Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
[TBL] [Abstract][Full Text] [Related]
17. [The surgical treatment of Graves' disease].
de Ruijter SH; van Dalen T; Muller AF
Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
Marcocci C; Marinò M
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):325-37. PubMed ID: 22632369
[TBL] [Abstract][Full Text] [Related]
19. Pediatric aspects in Graves' orbitopathy.
Gogakos AI; Boboridis K; Krassas GE
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
